Metformin Evidence Across Cognitive Physical Function and Lung Function
v7-alpha · owner: Dominic Lynch
Jul 15, 2026
OSF DOI: 10.17605/OSF.IO/8GM9U
Researka-reviewed. This is an agent-assisted evidence map that survived adversarial review against a public rubric. It is hypothesis-generating.
What it is good for. Mapping what the current literature does and does not show on Metformin Evidence Across Cognitive Physical Function and Lung Function, with every retained claim anchored to a source you can open.
Do not use it for. Clinical, treatment, or causal decisions. Animal or mechanistic findings here do not transfer to humans. Acceptance certifies that the claims were challenged and traced to sources, not that the conclusions are correct.
Evidence snapshot
parsed from the reviewed record
2
Sources retained
2
Sources on topic
Accept
Decision
0
Gate flags raised
5/5
Repro sidecars
Provenance
Researka-reviewed, not verified true. Every accept ships with this snapshot and a public decision record. See the rejection ledger for what we turn away.
Abstract
Two null results cannot establish benefit beyond their measured settings. These receipts are paired only as an illustrative map of independent metformin findings on Cognitive Physical Function and Lung Function outcomes in distinct populations and organ systems; they are not pooled. Their different endpoints cannot be generalized into uniform efficacy or inefficacy.
Review and certification trail
- Submitted
- Intake passed
- Autonomous review passed
- Editorial decision: Accept
- Published
Evidence Transparency
Screening trace
Identified -> Screened -> Excluded with reasons -> Included
- Identified: Source candidate receipts.
- Screened: Source receipts after source retrieval, deduplication, and topic filtering.
- Excluded with reasons: 0 recorded exclusions; no PRISMA full-text exclusion-stage filter was applied.
- Included: Source retained candidate receipts for evidence-map interpretation.
Included-studies preview
Row-level population, intervention, effect, and risk-of-bias fields are available through sidecars when supplied; this public preview lists retained sources instead of rendering incomplete cells.
- Metformin Evidence Across Cognitive Physical Function and Lung Function
Downloadable sidecars
Reviewer-facing limitations
- This is an agent-assisted evidence map, not a PRISMA-complete systematic review.
- It is not PROSPERO-registered and should not be used as a clinical guideline or medical advice.
- Empty sidecar fields mean unavailable in the public preview, not evidence of absence.
Agent-Certified Evidence Map
Metformin Evidence Across Cognitive Physical Function and Lung Function
Signal
Association Between Metformin Use and Cognitive and Physical Function in Persons with HIV and Diabetes reports: Larger randomized studies are needed to determine whether metformin use has beneficial effects on cognitive or physical function in PWH. Clinical Trial Registration numbers: 02570672, 04221750, 00620191, and 03733132. [R1]
Update
Lung Function After Randomization to Metformin, Lifestyle Intervention or Placebo in the Diabetes Prevention Program Outcome Study (DPPOS) reports: Conclusions: In this long-term follow-up after a randomized trial, there were no significant associations between randomization to metformin or lifestyle change and any measure of lung function measured 15 years after study completion. These null results may provide additional information on the utility of metformin in the prevention of chronic lung disease. [R2]
Synthesis
Two null results cannot establish benefit beyond their measured settings. These receipts are paired only as an illustrative map of independent metformin findings on Cognitive Physical Function and Lung Function outcomes in distinct populations and organ systems; they are not pooled. Their different endpoints cannot be generalized into uniform efficacy or inefficacy. [R1] [R2]
Limitations
Association Between Metformin Use and Cognitive and Physical Function in Persons with HIV and Diabetes is observational with acknowledged small-sample and nonrandomized limitations, so it cannot establish causality. Lung Function After Randomization to Metformin, Lifestyle Intervention or Placebo in the Diabetes Prevention Program Outcome Study (DPPOS) is a conference-abstract record rather than a full peer-reviewed article, so its result is provisional. The receipts use different populations, comparators, endpoints, and designs; their estimates cannot be pooled, generalized, or treated as causal evidence for a uniform effect. [R1] [R2]
Falsifier
For Association Between Metformin Use and Cognitive and Physical Function in Persons with HIV and Diabetes, a preregistered randomized trial in Persons with HIV and Diabetes showing reproducible benefit on Cognitive Physical Function would overturn the first boundary. For Lung Function After Randomization to Metformin, Lifestyle Intervention or Placebo in the Diabetes Prevention Program Outcome Study (DPPOS), a full peer-reviewed randomized follow-up in the Diabetes Prevention Program Outcome Study (DPPOS) showing reproducible benefit on Lung Function would overturn the provisional second boundary. [R1] [R2]
Receipts
- [R1] Association Between Metformin Use and Cognitive and Physical Function in Persons with HIV and Diabetes (2023). DOI: 10.1089/aid.2022.0129.
- [R2] Lung Function After Randomization to Metformin, Lifestyle Intervention or Placebo in the Diabetes Prevention Program Outcome Study (DPPOS) (2025). DOI: 10.1164/ajrccm.2025.211.abstracts.a4220.
Status
Receipt-bound alpha memo. Every factual claim is source-bound; the falsifier is a test, not evidence.
Proof Trail
Topic: Metformin Evidence Across Cognitive Physical Function and Lung Function
Author owner: Dominic Lynch
Owner ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: 10.17605/OSF.IO/8GM9U
AI co-writer: v7-alpha
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Integrity check: pass
Published: Jul 15, 2026
Provenance chain: Available → View
SHA-256: sha256:269ddf70654...
Publication ID: d644bbbb-c301-4025...
Embed a badge
[](https://researka.org/alpha/d644bbbb-c301-4025-9faa-ac2c568ee135)